Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Understanding the biological relevance of reexpression of developmental molecules in pathological conditions is crucial for the development of new therapies. In this study, we report the increased expression of stathmin, a developmentally regulated tubulin-binding protein, in the brains of patients with multiple sclerosis (MS). In physiological conditions, stathmin immunoreactivity was observed in polysialic acid-neural cell adhesion molecule-positive migratory progenitors in the subventricular zone, and its expression progressively decreased as the cells matured into oligodendrocytes (OLs). In MS patients, however, stathmin levels were elevated in 2′,3′-cyclic nucleotide 3′-phosphodiesterase-positive OLs, in 10 of 10 bioptic samples analyzed. Increased levels of stathmin were confirmed by Western blot analysis of normal-appearing white matter samples from MS brains. In addition, using mass spectrometry, stathmin was identified as the main component of a specific myelin protein fraction consistently increased in MS preparations compared with controls. To test the biological relevance of increased stathmin levels, primary OL progenitors were transfected using a myc-tagged stathmin cDNA and were allowed to differentiate. Consistent with a distinct role played by this molecule in cells of the OL lineage at different developmental stages, transient transfection in progenitors favored the bipolar migratory phenotype but did not affect survival. However, sustained stathmin levels in differentiating OLs, because of overexpression, resulted in enhanced apoptotic susceptibility. We conclude that stathmin expression in demyelinating disorders could have a dual role. On one hand, by favoring the migratory phenotype of progenitors, it may promote myelin repair. On the other hand, stathmin in mature OLs may indicate cell stress and possibly affect survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · cited 1×
“Because adult progenitors in the SVZ have been shown to be mobilized in response to demyelinating conditions in the brain (Nait-Oumesmar et al., 1999; Decker et al., 2002), we asked whether the mobilized cells were also stathmin immunoreactive.”
BackgroundEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · cited 1×
“It has also been demonstrated that these SVZ cells tend to reacquire this gliogenic potential in response to demyelinating conditions (Gensert and Goldman, 1997; NaitOumesmar et al., 1999; Picard-Riera et al., 2002).”
BackgroundChun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A., & Vartanian, T. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304154 · Cited by 170
Cited by
Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings
Marin‐Husstege, M., He, Y., Li, J., Kondo, T., Sablitzky, F., & Casaccia‐Bonnefil, P. (2006) · Glia · doi:10.1002/glia.20385 · Cited by 91
“level of complexity of their cellular processes, as previously described ( Liu et al., 2003, 2005 ).”
MethodSelf-citationThe Cytoskeleton in Oligodendrocytes: Microtubule Dynamics in Health and Disease
Richter-Landsberg, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9017-7 · Cited by 89
The cancer drug tamoxifen: A potential therapeutic treatment for spinal cord injury
Guptarak, J., Wiktorowicz, J. E., Sadygov, R. G., Zivadinovic, D., Paulucci-Holthauzen, A. A., Vergara, L., & Nesic, O. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3108 · Cited by 38
“Among proteins where abundance was significantly decreased after SCI and then partially restored by TMX, we found markers of oligodendrocytes, such as 2 ¢ ,3 ¢ -cyclic nucleotide 3 ¢ -phosphodiesterase (CNPase), 40 and of oligodendrocyte progenitors (stathmin), 41 as well as myelin (enoyl co-A).”
Metadata
- Authors
- Liu, A., Stadelmann, C., Moscarello, M., Bruck, W., Sobel, A., Mastronardi, F. G., & Casaccia-Bonnefil, P.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-01-19
- Volume
- 25
- Issue
- 3
- Pages
- 737-747
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2134400415
- Cited by
- 51
- References
- 3
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders. https://app.cochat.ai/papers/10.1523/jneurosci.4174-04.2005
- The paper
- Liu, A., Stadelmann, C., Moscarello, M., Bruck, W., Sobel, A., Mastronardi, F. G., & Casaccia-Bonnefil, P. (2005). Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4174-04.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.